IBO Impact BioMedical Inc.

Price (delayed)

$0.5561

Market cap

$59.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.29

Enterprise value

$59.94M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

Impact Biomedical, Inc. (“IBIO”) currently is a holding company operating mainly through our majority owned subsidiary, Global BioLife, Inc., which was incorporated on April 14, 2017. The Company is committed ...

Highlights
The debt has dropped by 100% year-on-year
The company's EPS has surged by 88% YoY and by 24% QoQ
The equity has soared by 198% YoY but it fell by 7% QoQ
Impact BioMedical's net income has increased by 49% YoY but it has decreased by 9% QoQ
Impact BioMedical's quick ratio has decreased by 28% from the previous quarter and by 13% YoY

Key stats

What are the main financial stats of IBO

IBO stock price

How has the Impact BioMedical stock price performed over time
Intraday
2.62%
1 week
8.17%
1 month
-12.48%
1 year
14.42%
YTD
10.12%
QTD
-7.32%

Financial performance

How have Impact BioMedical's revenue and profit performed over time
Revenue
$39,000
Gross profit
-$395,000
Operating income
-$5.56M
Net income
-$12.86M
Gross margin
-1,012.8%
Net margin
-32,969.2%
IBO's operating income has surged by 81% year-on-year but it is down by 30% since the previous quarter
Impact BioMedical's net income has increased by 49% YoY but it has decreased by 9% QoQ
IBO's revenue is up by 22% since the previous quarter
Impact BioMedical's gross margin has increased by 17% from the previous quarter

Price vs fundamentals

How does IBO's price correlate with its fundamentals

Growth

What is Impact BioMedical's growth rate over time

Valuation

What is Impact BioMedical stock price valuation
P/E
N/A
P/B
5.23
P/S
1,536.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,536.91
The company's EPS has surged by 88% YoY and by 24% QoQ
The equity has soared by 198% YoY but it fell by 7% QoQ
The stock's price to sales (P/S) is 66% more than its last 4 quarters average of 901.6
IBO's revenue is up by 22% since the previous quarter

Efficiency

How efficient is Impact BioMedical business performance
The return on assets has declined by 13% since the previous quarter but it has grown by 6% year-on-year
The company's return on sales rose by 10% QoQ

Dividends

What is IBO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IBO.

Financial health

How did Impact BioMedical financials performed over time
Impact BioMedical's total liabilities has plunged by 82% YoY but it has increased by 28% from the previous quarter
The current ratio is down by 37% since the previous quarter
The debt is 100% smaller than the equity
The equity has soared by 198% YoY but it fell by 7% QoQ
The debt to equity has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.